Inato

Executive Summary

Inato is a digital health platform optimizing clinical trial recruitment, particularly in oncology. By connecting pharmaceutical sponsors with a global network of community-based and academic research sites, it addresses the inefficiencies and lack of diversity in traditional trial recruitment. The company aims to make trials more accessible and efficient, leveraging its network to identify and activate qualified patients outside large academic centers. With a commercial-stage presence and a focus on a high-growth area, Inato is well-positioned to benefit from the increasing demand for decentralized and diverse clinical trials. The company's platform has the potential to significantly reduce trial enrollment times and costs, while improving patient representativeness.

Upcoming Catalysts (preview)

• Q3 2026Partnership with a top 20 pharma company for oncology trial recruitment70% success
• Q4 2026Launch of AI-powered patient matching feature80% success
• Q2 2026Series C funding round for international expansion60% success